New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Clinical trial NCT00044577 · COMPLETED

Trial details

NCT number: NCT00044577
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus I HIV Infection

Start date: 2002-07-16
Primary completion: 2004-05-25
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.